Michelle T. Long

7.9k total citations · 2 hit papers
111 papers, 3.1k citations indexed

About

Michelle T. Long is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Hepatology. According to data from OpenAlex, Michelle T. Long has authored 111 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Epidemiology, 31 papers in Endocrinology, Diabetes and Metabolism and 31 papers in Hepatology. Recurrent topics in Michelle T. Long's work include Liver Disease Diagnosis and Treatment (64 papers), Liver Disease and Transplantation (24 papers) and Diet, Metabolism, and Disease (22 papers). Michelle T. Long is often cited by papers focused on Liver Disease Diagnosis and Treatment (64 papers), Liver Disease and Transplantation (24 papers) and Diet, Metabolism, and Disease (22 papers). Michelle T. Long collaborates with scholars based in United States, Denmark and Canada. Michelle T. Long's co-authors include Joseph M. Massaro, Udo Hoffmann, Alison Pedley, Emelia J. Benjamin, Joseph K. Lim, Mazen Noureddin, Daniel Levy, Ramachandran S. Vasan, Jiantao Ma and Caroline S. Fox and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Michelle T. Long

106 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review

2022 178 citations Michelle T. Long, Mazen Noureddin et al. Gastroenterology profile →
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis

2025 170 citations Michelle T. Long et al. profile →

Peers

Michelle T. Long

EPIDE

EDM

HEPAT

PHYSI

Kyung Eun Yun South Korea

Cheng Han Ng Singapore

Mark Muthiah Singapore

Ki‐Chul Sung South Korea

Bo Kyung Koo South Korea

Kyungdo Han South Korea

Wen Hui Lim Singapore

Violeta Raverdy France

Yuhong Chen China

Andrea O. Y. Luk Hong Kong

Kyung Eun Yun South Korea

Michelle T. Long

1.5k ×0.8

EPIDE

875 ×1.0

EDM

424 ×0.7

HEPAT

638 ×1.1

PHYSI

326 ×0.6

Citations per year, relative to Michelle T. Long Michelle T. Long (= 1×) peers Kyung Eun Yun

Countries citing papers authored by Michelle T. Long

Since Specialization

Citations

This map shows the geographic impact of Michelle T. Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle T. Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle T. Long more than expected).

Fields of papers citing papers by Michelle T. Long

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle T. Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle T. Long. The network helps show where Michelle T. Long may publish in the future.

Co-authorship network of co-authors of Michelle T. Long

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle T. Long. A scholar is included among the top collaborators of Michelle T. Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle T. Long. Michelle T. Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sun, Natalie, Jiantao Ma, Vanessa Xanthakis, et al.. (2025). The cross–sectional association between ultra-processed food intake and metabolic dysfunction-associated steatotic liver disease. Clinical Nutrition ESPEN. 66. 215–220. 2 indexed citations

Niezen, Sebastian, Aarshi Vipani, Ju Dong Yang, et al.. (2024). Food Insecurity in Hispanic Populations Is Associated with an Increased Risk of Hepatic Steatosis: A Nationally Representative Study. Journal of Clinical Medicine. 13(11). 3206–3206. 2 indexed citations

Long, Michelle T., et al.. (2024). Eggs, Dietary Choline, and Nonalcoholic Fatty Liver Disease in the Framingham Heart Study. Journal of Nutrition. 155(3). 923–935. 2 indexed citations

Sun, Natalie, et al.. (2024). Prevalence of Steatotic Liver Disease Subtypes and Association With Metabolic Risk Factors in the Framingham Heart Study. Clinical Gastroenterology and Hepatology. 22(11). 2330–2333. 1 indexed citations

Cooper, Leroy L., Vanessa Xanthakis, Emelia J. Benjamin, et al.. (2024). Association of Aortic Stiffness and Pressure Pulsatility With Noninvasive Estimates of Hepatic Steatosis and Fibrosis: The Framingham Heart Study. Arteriosclerosis Thrombosis and Vascular Biology. 44(7). 1704–1715. 1 indexed citations

Xu, Xixi, et al.. (2023). Real-World Implications of the American Gastroenterology Association Nonalcoholic Fatty Liver Disease Clinical Care Pathway in the US Adult Population. Gastroenterology. 164(4). 688–689.e4. 3 indexed citations

Long, Michelle T., et al.. (2023). Eat to Treat: The Methods and Assessments of a Culinary Medicine Seminar for Future Physicians and Practicing Clinicians. Nutrients. 15(22). 4819–4819. 1 indexed citations

Rich, Katherine M., et al.. (2023). The Impact of Incarceration on Readmissions Among Patients With Inflammatory Bowel Disease Hospitalized at a Community Hospital. SHILAP Revista de lepidopterología. 2(5). 660–665. 1 indexed citations

Long, Michelle T., Mazen Noureddin, & Joseph K. Lim. (2022). AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review. Gastroenterology. 163(3). 764–774.e1. 178 indexed citations breakdown →

10.

Long, Michelle T., et al.. (2022). The NAFLD Decompensation Risk Score: External Validation and Comparison to Existing Models to Predict Hepatic Events in a Retrospective Cohort Study. Journal of Clinical and Experimental Hepatology. 13(2). 233–240. 5 indexed citations

11.

Naimi, Timothy S., et al.. (2022). Nonheavy Alcohol Use Associates With Liver Fibrosis and Nonalcoholic Steatohepatitis in the Framingham Heart Study. Clinical Gastroenterology and Hepatology. 21(11). 2854–2863.e2. 16 indexed citations

12.

Kammerlander, Andreas A., Asya Lyass, Taylor F. Mahoney, et al.. (2021). Sex Differences in the Associations of Visceral Adipose Tissue and Cardiometabolic and Cardiovascular Disease Risk: The Framingham Heart Study. Journal of the American Heart Association. 10(11). e019968–e019968. 63 indexed citations

13.

Fricker, Zachary, Naga Chalasani, Bashar M. Attar, et al.. (2020). MELD–Na Is More Strongly Associated with Risk of Infection and Outcomes Than Other Characteristics of Patients with Cirrhosis. Digestive Diseases and Sciences. 66(1). 247–256. 2 indexed citations

14.

Long, Michelle T., Xiaoyu Zhang, Hanfei Xu, et al.. (2020). Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study. Hepatology. 73(2). 548–559. 77 indexed citations

15.

Long, Michelle T., et al.. (2020). Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease. Metabolism. 111. 154259–154259. 56 indexed citations

16.

Ma, Jiantao, Rachel Hennein, Chunyu Liu, et al.. (2018). Improved Diet Quality Associates With Reduction in Liver Fat, Particularly in Individuals With High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease. Gastroenterology. 155(1). 107–117. 139 indexed citations

17.

Lee, Jane, Alison Pedley, Udo Hoffmann, et al.. (2017). Longitudinal Associations of Pericardial and Intrathoracic Fat With Progression of Coronary Artery Calcium (from the Framingham Heart Study). The American Journal of Cardiology. 121(2). 162–167. 8 indexed citations

18.

Ko, Darae, Eric M. Riles, Jared W. Magnani, et al.. (2016). Metabolomic Profiling in Relation to New-Onset Atrial Fibrillation (from the Framingham Heart Study). The American Journal of Cardiology. 118(10). 1493–1496. 23 indexed citations

19.

Long, Michelle T., et al.. (2016). Recent Trends in Employer-Sponsored Health Insurance Premiums. JAMA. 315(1). 18–18. 3 indexed citations

20.

Shao, Di, Jingyan Han, Xiuyun Hou, et al.. (2016). Glutaredoxin-1 Deficiency Causes Fatty Liver and Dyslipidemia by Inhibiting Sirtuin-1. Antioxidants and Redox Signaling. 27(6). 313–327. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact